Press Release

Accuro Biologics Ltd announces launch of new outsourcing options for specialist services

CHICAGO, IL-- April 10, 2006 --- Today at the BIO 2006 conference, Accuro Biologics Ltd, a privately held biotechnology services company, launches the availability of its specialty services.

Formed during late 2005, Accuro Biologics was started by a team of biopharma services specialists. The company provides services within its core capabilities of antibody engineering, mammalian cell line engineering and T-cell epitope evaluation. Together, the management team has worked on over 40 therapeutic antibody candidates for a variety of companies. Past work includes antibodies that have advanced into clinical development and antibodies and other proteins engineered using a variety of platforms and immunogenicity evaluation strategies.

"Since becoming fully operational during November '05 the company has built excellent relations with its clients and following successful delivery of some initial programs we are confident we have the right team, facilities and service offerings to build a sustainable and exciting company for the long term," said Graham Carter, Managing Director of Accuro Biologics.

About Accuro Biologics Ltd

Accuro Biologics is a research services company serving the pharmaceutical, biotechnology and wider research community to provide access to advanced capabilities in protein and antibody engineering, mammalian cell line engineering and immunogenicity profiling. The company is UK-based and operates from its own fully equipped laboratories within the Aberdeen Science and Technology Park (Aberdeen, Scotland). For more information, please contact:

Graham Carter
Managing Director
Tel: +44 (0)1224 707337
Email: graham.carter@accurobio.com

Return to Press Releases